Status:
COMPLETED
Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis
Lead Sponsor:
Dermatology Consulting Services, PLLC
Conditions:
Psoriasis Vulgaris
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The objective of this research is to demonstrate superior anti-inflammatory effects, as demonstrated by a reduction in TNF-a and IL-17A, with tazarotene/halobetasol lotion in patients with mild to mod...
Detailed Description
Male or female subjects with mild to moderate plaque type psoriasis will present to the research center for evaluation for study entry. They will have been advised to present to the research center wi...
Eligibility Criteria
Inclusion
- Males or non-pregnant females 18+ years of age.
- Plaque type mild to moderate psoriasis suitable for topical treatment.
- The presence of 2 plaques suitable for tape stripping
- Subjects must be willing to allow a series of tape pieces to be pressed and removed from 2 target psoriasis plaques.
- Subjects must be in general good health as determined from a medical history.
- Subjects must read and sign the informed consent form after the nature of the study has been fully explained.
Exclusion
- Subjects with known allergies or sensitivities to ingredients contained in the test products.
- Subjects with an allergy to latex or adhesives.
- Subjects with pustular or erythrodermic psoriasis.
- Subjects who are pregnant or nursing or planning to become pregnant during the course of the study.
- Subjects who are currently participating in any other clinical study (i.e., dermal patch, use tests, investigational drug or devices, etc.).
- Subjects viewed by the investigator as not being able to complete the study.
- Subjects using any type of lotion, medication, or other topical product to the psoriasis plaques.
Key Trial Info
Start Date :
July 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 13 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06042647
Start Date
July 13 2023
End Date
November 13 2023
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dermatology Consulting Services, PLLC
High Point, North Carolina, United States, 27262